Dendreon Inks $17M Deal In Shareholder Action
A federal judge has given preliminary approval to a $16.5 million settlement that would end a class action alleging that Dendreon Corp. deceived investors about the approval process for the biotechnology...To view the full article, register now.
Already a subscriber? Click here to view full article